Patients of C-OPO, who were under outpatient observation after Acute Phase I of the program, had significantly lower serum BDNF and worse motor disorders on the 90th day of stroke than those of A-Rehab-Traditional-AR and B-Rehab-AR. The gene discussed is BDNF; the disease is stroke disorder.